Carcinoma: all 6,718 studies
Page 30 of 68. Open to participants first (1,141), then studies with results posted, then the rest; newest registration first within each.
- BOLD MRI and FMISO PET for the Assessment of Hypoxic Tumor Microenvironment in Patients with Oligometastatic Liver Cancer Undergoing Yttirum-90 Selective Internal Radiation TherapyCompletedNCT05250895Early Phase 1
- Effects of Ribociclib and Palbociclib on Tumor and Blood Characteristics in Patients With Metastatic Breast CancerWithdrawnNCT05244434Not applicable
- Clinical Study of MAK Immune Cells in the Treatment of PHCStatus unknownNCT05242757Not applicable
- (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion MutationsTerminatedNCT05241873Phase 1
- OREIOS International StudyCompletedNCT05239507
- SMMART Adaptive Clinical Treatment (ACT) TrialWithdrawnNCT05238831Early Phase 1
- The Efficacy and Safety of HLX07 in Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma (CSCC)Status unknownNCT05238363Phase 2
- A Prospective Study of UCAD for Diagnosing Benign or Malignant Biliary Obstruction and Follow-upStatus unknownNCT05237193
- Identification of Image Phenotypes to Predict Recurrence After Resection of Hepatocellular CarcinomaCompletedNCT05235490
- A Safety and Preliminary Efficacy Study of SBT6290 Alone and in Combination With PD-(L)1 Inhibitors in Select Advanced Solid TumorsWithdrawnNCT05234606Phase 1/2
- Multi-omics Characterization of Pancreatic Neuroendocrine Tumors and CarcinomasStatus unknownNCT05234450
- HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or FailureStatus unknownNCT05233358Not applicable
- Study of Anlotinib With Chemoradiation for Patients With Locally Advanced Nasopharyngeal CarcinomaStatus unknownNCT05232552Phase 2
- Hepatic Arterial Infusion of Raltetrexed With Oxaliplatin(SALOX) Versus FOLFOX in Advanced Hepatocellular CarcinomaStatus unknownNCT05231382Phase 3
- A Study of SGN-ALPV in Advanced Solid TumorsTerminatedNCT05229900Phase 1
- PD-1 Combined With Intensity Modulated Radiation Therapy in the Treatment of Intermediate-risk Nasopharyngeal CarcinomaStatus unknownNCT05229315Phase 2
- A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian CancerTerminatedNCT05226507Phase 1
- A Study of Lenvima (Lenvatinib) in Korean Unresectable Hepatocellular Carcinoma (uHCC) ParticipantsCompletedNCT05225207
- Evaluating Patient Reported Outcomes in Radiation Therapy, the PRO-RT StudyCompletedNCT05224271
- Comprehensive Genomic Profiling Combined With Real Life Data of "The German-Registry of Incidental Gallbladder Carcinoma"Active, not recruitingNCT05222854
- RM-1995 Photoimmunotherapy, as Monotherapy or Combined With Pembrolizumab, in Patients With Advanced CuSCC and HNSCCWithdrawnNCT05220748Phase 1
- A Study of Probiotics Administration in the Immunotherapy of Urothelial Bladder CarcinomaStatus unknownNCT05220124Phase 4
- RTX-224 Monotherapy in Patients With Solid TumorsTerminatedNCT05219578Phase 1/2
- Treatment Pause Versus Treatment Continuation in IMDC Good or Intermediate Risk With Only One Adverse Prognostic Factor in mRCC Patients With an Objective Response at 12 Months of Treatment With PD1/ PDL1 ICIs + VEGFR-Tyrosine Kinase InhibitorsActive, not recruitingNCT05219318Phase 3
- An Investigation of Biomarker Candidate Molecules in Laryngeal CarcinomaCompletedNCT05217147
- Pemigatinib in Subjects With Adenosquamous Carcinoma of the PancreasWithdrawnNCT05216120Phase 2
- Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid TumorsActive, not recruitingNCT05215574Phase 1
- A Trial of Hepatic Arterial Infusion Combined With Bevacizumab and Sintilimab for Unresectable A-staged Hepatocellular Carcinoma in BCLC Classification (D-TRIPLET)Status unknownNCT05214339Phase 2
- Expanded Activated Lymphocytes (EAL) as Adjuvant Therapy in Patients With HCC at High Risk of Recurrence After Radical ResectionStatus unknownNCT05213637Phase 2
- Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCCStatus unknownNCT05213312Phase 2/3
- A Real-world Study of Donafenib Combined With TACE-based Treatment in Patients With Unresectable HCCStatus unknownNCT05205629
- Impact of Human Papillomavirus (HPV) Vaccination on Burden of Disease in Patients with Actinic KeratosisActive, not recruitingNCT05202860Phase 2
- The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCsStatus unknownNCT05202275Phase 2
- Non-invasive MRI Subclassification of Heptocellular Carcinoma - HepCaSt-StudyStatus unknownNCT05202015
- Tumor Recurrence After Abdominal-perineal Amputation in Squamous Cell Carcinoma of the AnusCompletedNCT05201105
- A Single Center Real-world Study of Donafenib in the Treatment of Hepatocellular Carcinoma in Routine Clinical PracticeStatus unknownNCT05200221
- Correlation Between the Efficacy of Neoadjuvant Chemotherapy Combined With Immunotherapy of Operable Thoracic Esophageal Squamous Cell Carcinoma and the Metabolites of Intestinal FloraStatus unknownNCT05199649Not applicable
- A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid MalignanciesActive, not recruitingNCT05199272Phase 1/2
- A Clinical Trial to Evaluate Tolerability and Security of TQB2858 Injection in Subjects With Advanced Pancreatic CarcinomaTerminatedNCT05193604Phase 1
- A Nomogram Model to Predict Central Lymphnode Metastasis in Thyroid Papillary CarcinomaCompletedNCT05191927
- A Study of Neoadjuvant Tislelizumab With SBRT in Patients With Resectable Hepatocellular CarcinomaActive, not recruitingNCT05185531Phase 1
- Utilization of MAsS in Patients Undergoing LT for HCCTerminatedNCT05184283
- Medullary Colonic CarcinomaCompletedNCT05184153
- ASP-1929 Photoimmunotherapy (PIT) Study in Patients With Recurrent Head/Neck CancerActive, not recruitingNCT05182866Phase 2
- Clinical Study on BIFICO Accelerating Postoperative Liver Function Recovery in Patients With Hepatocellular CarcinomaCompletedNCT05178524Not applicable
- GT90001 Plus Nivolumab in Patients With Advanced Hepatocellular CarcinomaActive, not recruitingNCT05178043Phase 2
- Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast CancerWithdrawnNCT05177796Phase 2
- Avelumab, Palbociclib and Axitinib in Advanced RCCWithdrawnNCT05176288Phase 2
- Effectiveness of Neoadjuvant Chemotherapy Combined With PD-1 Monoclonal Antibody in the Treatment of Operable Esophageal Squamous Cell CarcinomaStatus unknownNCT05174325Phase 2
- Stereotactic Ablative Radiotherapy for Oligometastatic Hepatocellular CarcinomaStatus unknownNCT05173610Phase 2
- Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and NeckActive, not recruitingNCT05172258Phase 2
- Surufatinib in Advanced Hepatocellular Carcinoma Based on Single-cell Sequencing of Tumor SamplesStatus unknownNCT05171439Phase 2
- Camrelizumab in Combination With Apatinib Plus NK Cell for Advanced HCCStatus unknownNCT05171309Phase 2
- Diagnosis of Renal Cell Carcinoma on 68Ga-PSMA PET-CT and Radioligand Therapy With 177Lu-EB-PSMA-617Status unknownNCT05170555Not applicable
- Trastuzumab and Standard Treatment With Chemo- and Immunotherapy as First Line Treatment for HER2 Positive Esophageal Squamous Cell Carcinoma PatientsStatus unknownNCT05170256Phase 2
- A Study of Preferences of Participants and Oncologists for the Characteristics of the Treatment for Renal Cell Carcinoma (RCC) In Spain And PortugalCompletedNCT05168436
- Donafenib Combine With Sintilimab and HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）in the First-line Treatment of Unresectable Hepatocellular CarcinomaStatus unknownNCT05166772Phase 2
- Study of NG-350A Plus Pembrolizumab in Metastatic or Advanced Epithelial Tumours (FORTIFY)CompletedNCT05165433Phase 1
- JMT101 Combined With Afatinib in Patients With Advanced Esophageal Squamous Cell Carcinoma After Standard TherapyStatus unknownNCT05164848Phase 1
- Niraparib And Sintilimab In Recurrent/Metastatic Nasopharyngeal CarcinomaStatus unknownNCT05162872Phase 2
- Magseed and Magtrace Localization for Breast CancerCompletedNCT05161507
- Donafenib Combined With TACE as Adjuvant Therapy of Patients With Hepatocellular CarcinomaStatus unknownNCT05161143Phase 2
- Neoadjuvant Nivolumab for Upper Tract Urothelial CarcinomaStatus unknownNCT05160285Phase 2
- A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell CarcinomaStatus unknownNCT05157763Phase 1/2
- Y-90 Versus SBRT for Inoperable HCCWithdrawnNCT05157451Phase 2
- Correlation of Fecal Microbiome and Its Metabolites With Outcome of Radiotherapy in Head and Neck CarcinomaActive, not recruitingNCT05156177
- Yang Yin Fu Zheng Jie Du Therapy in HBV Associated Hepatocellular Carcinoma Based on the Platelet Count/Splenic Length-Diameter RatioStatus unknownNCT05154812Early Phase 1
- (HARMONY) Study of BLU-701 in EGFR-mutant NSCLCTerminatedNCT05153408Phase 1
- Fu Zheng Jie Du Hua Yu Principle For Treatment Of Severe HBV Related Hepatocellular Carcinoma (FZJDHYPFTOSHBVHCC)Status unknownNCT05152498Early Phase 1
- Circulating microRNA 21 Expression Level Before and After Neoadjuvant Systemic Therapy in Breast CarcinomaStatus unknownNCT05151224
- Association of Salivary Amino Acid Level With OSCC Identified By Liquid Chromatography Mass SpectroscopyStatus unknownNCT05150509
- Olfactory Change After Chemo-radiotherapy for Nasopharyngeal CarcinomaStatus unknownNCT05146050
- Acupuncture for Dysphagia in Head and Neck Squamous Cell CarcinomaStatus unknownNCT05143268
- Immunohistochemical Expression of CXCL5 as a Valuable Prognostic Marker in Urinary Bladder Urothelial CarcinomaStatus unknownNCT05139134
- Laser Treatment of Basal Cell Carcinoma Under Imaging GuidanceCompletedNCT05138328Not applicable
- Neoadjuvant Combination of Atezolizumab/Bevacizumab Versus Neoadjuvant Radiation TherapyTerminatedNCT05137899Phase 2
- Sintilimab Combined With Chemotherapy and SBRT in Limited Metastatic Head and Neck Squamous Cell Carcinoma (LM-HNSCC)Status unknownNCT05136768Phase 2
- Patient Reported Outcomes by Patients With Metastatic Renal Cell CarcinomaStatus unknownNCT05135832Not applicable
- HAIC Combined With Camrelizumab and TKI for Unresectable Hepatocellular Carcinoma After TACE FailureStatus unknownNCT05135364Phase 2
- Regorafenib After Progression on Atezolizumab Plus Bevacizumab in Advanced HCCStatus unknownNCT05134532Phase 2
- Clinical Study of the Efficacy and Safety of Transhepatic Arterial Chemoembolization Combined With Tislelizumab and Lenvatinib in Patients With Advanced Unresectable Hepatocellular CarcinomaStatus unknownNCT05131698Early Phase 1
- Neo-NTP-CRT for Locally Advanced ESCCStatus unknownNCT05130684Phase 2
- Influence of Social Determinants of Health on the Management of HCC in the French National Cohort Study CHIEFActive, not recruitingNCT05128123
- RBN-2397 in Combination With Pembrolizumab in Patients With SCCLActive, not recruitingNCT05127590Phase 1/2
- DERM US and EU Validation StudyCompletedNCT05126173
- Anlotinib Plus Everolimus as First-line Treatment for Advanced Non Clear Cell Renal Cell CarcinomaStatus unknownNCT05124431Phase 2
- A Study of Treatment Patterns and Clinical Outcomes in First Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (1L R/M SCCHN) Participants in EuropeCompletedNCT05123950
- A Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)TerminatedNCT05121948Phase 1
- A Clinical Trial to Evaluate TQB2858 Injection Combined With Anlotinib Hydrochloride Capsule in the Treatment of Recurrent or Metastatic Advanced Endometrial CarcinomaStatus unknownNCT05121363Phase 2
- A Pilot Study Evaluating a Ketogenic Diet Concomitant to Nivolumab and Ipilimumab in Patients With Metastatic Renal Cell CarcinomaTerminatedNCT05119010Not applicable
- Comparison of Outcomes of Patients With Stage IV Chronic Limb-threatening Ischemia and Colorectal CancerCompletedNCT05116696
- Does Timing of Completion Radical Cholecystectomy Determine the Survival in Incidental Carcinoma GallbladderCompletedNCT05114369
- Effect and Safety of Recombinant Human Adenovirus Type 5 in Advanced HCC With Stable Disease After Sorafenib TreatmentStatus unknownNCT05113290Phase 4
- Immunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative TherapyCompletedNCT05112627
- Prognostic Prediction of NPC Based on MR Diffusion-weighted ImagingStatus unknownNCT05112510
- Comparison of Hepatic Intraarterial Versus Systemic Intravenous 68Ga-PSMA PET/CT for Detection of Hepatocellular CarcinomaWithdrawnNCT05111314Early Phase 1
- Trial of PXS-5505 Combined With First Line Atezolizumab Plus Bevacizumab For Treating Patients With Unresectable Hepatocellular CarcinomaWithdrawnNCT05109052Phase 1/2
- Study of MRx0518 and Avelumab in Patients With Urothelial CarcinomaWithdrawnNCT05107427Phase 2
- Safety and Efficacy of Autoimmune Cell Therapy for Patients With Hepatocellular CarcinomaStatus unknownNCT05105815Early Phase 1
- A Phase I/II Open Label Single Centre Trial to Assess the Safety, Tolerability and Efficacy of Single Dose Neoadjuvant Anti-CLEVER-1 Antibody Bexmarilimab in Localised Renal Cell and Colon CarcinomaWithdrawnNCT05104905Phase 1/2